|
KMID : 0613820200300121118
|
|
Journal of Life Science
2020 Volume.30 No. 12 p.1118 ~ p.1127
|
|
|
Platelets as a Source of Peripheral Aβ Production and Its Potential as a Blood-based Biomarker for Alzheimer’s Disease
|
|
Kang Jae-Seon
Choi Yun-Sik
|
|
|
Abstract
|
|
|
|
Alzheimer’s disease causes progressive neuronal loss that leads to cognitive disturbances. It is not currently curable, and there is no way to stop its progression. However, since medical treatment for Alzheimer’s disease is most effective in the early stages, early detection can provide the best chance for symptom management. Biomarkers for the diagnosis of Alzheimer’s disease include amyloid β (Aβ) deposition, pathologic tau, and neurodegeneration. Aβ deposition and phosphorylated tau can be detected by cerebrospinal fluid (CSF) analysis or positron emission tomography (PET). However, CSF sampling is quite invasive, and PET analysis needs specialized and expensive equipment. During the last decades, blood-based biomarker analysis has been studied to develop fast and minimally invasive biomarker analysis method. And one of the remarkable findings is the involvement of platelets as a primary source of Aβ in plasma. Aβ can be transported across the blood?brain barrier, creating an equilibrium of Aβ levels between the brain and blood under normal condition. Interestingly, a number of clinical studies have unequivocally demonstrated that plasma Aβ42/Aβ40 ratios are reduced in mild cognitive impairment and Alzheimer’s disease. Together, these recent findings may lead to the development of a fast and minimally invasive early diagnostic approach to Alzheimer’s disease. In this review, we summarize recent advances in the biomarkers of Alzheimer’s disease, especially the involvement of platelets as a source of peripheral Aβ production and its potential as a blood-based biomarker.
|
|
|
KEYWORD
|
|
|
Alzheimer’s disease, amyloid β, biomarker, blood, platelet
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|